Structural

Atrial and Ventricular Functional MR: Treatment Implications

9 min.

Innovalve TMVR A new transcatheter mitral valve replacement system

10 min.

AltaValve

7 min.

Highlife

5 min.

Cephea

5 min.

M3 Trial (Encircle)

5 min.

Next Generation TMVR Devices: A Step Forward in Patient Selection and Eligibility?

18 min.

Are TMVR Devices Designed to Meet the Tricuspid Needs? – Technological Challenges and Opportunities for Innovation

8 min.

Featured TAVR Innovation: Treatment of Infective Endocarditis (IE) Using Drug-Eluting Transcatheter Valve Replacement (DE - TAVR)

7 min.

Interventional Perspectives and Emerging Therapeutic Options

6 min.

APOLLO Trial (Intrepid)

5 min.

ENCIRCLE Trial (M3)

5 min.

SUMMIT Trial (Tendyne)

5 min.

TMVR Performance in Real World Anatomies: Time to Consider Device Version 2.0?

6 min.

Intrepid – APOLLO MAC Cohort

2 min.

Tendyne – SUMMIT MAC Cohort

3 min.

Transfemoral Sapien in MAC

5 min.

Modular Transcatheter Transseptal “ReValvable” Mitral Valve Replacement (ReValve): FIH Results

5 min.

Outcomes of Mitral Regurgitation Patients Screen Failed for LVOT Obstruction Treated Using Altavalve

6 min.

Transfemoral TMVR: Intermediate-Term Outcomes From the Intrepid Early Feasibility Study

6 min.

Central Wrapping Concept for TMVR (Innovalve): Device Description and Early Clinical Results

5 min.

The Opus VR Valve: A Novel TMVR Tethered to the Ventricular Septum (Opus Medical)

3 min.

Choice of Optimal Transcatheter Treatment for Mitral Insufficiency: 2-Year Real-World Outcomes in the CHOICE MI International Registry

6 min.